Compare CINF & KVUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CINF | KVUE |
|---|---|---|
| Founded | 1950 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Specialty Chemicals |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.7B | 32.9B |
| IPO Year | 1994 | 2023 |
| Metric | CINF | KVUE |
|---|---|---|
| Price | $184.23 | $19.48 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $178.75 | $19.45 |
| AVG Volume (30 Days) | 803.5K | ★ 16.6M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | 2.30% | ★ 4.82% |
| EPS Growth | 4.40 | ★ 40.74 |
| EPS | ★ 1.75 | 0.25 |
| Revenue | $12,631,000,000.00 | ★ $15,124,000,000.00 |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | $6.77 | $2.63 |
| P/E Ratio | $104.46 | ★ $77.12 |
| Revenue Growth | ★ 11.41 | N/A |
| 52 Week Low | $143.87 | $14.02 |
| 52 Week High | $194.81 | $22.44 |
| Indicator | CINF | KVUE |
|---|---|---|
| Relative Strength Index (RSI) | 58.22 | 59.24 |
| Support Level | $159.75 | $16.83 |
| Resistance Level | $194.81 | $20.13 |
| Average True Range (ATR) | 4.32 | 0.39 |
| MACD | -0.34 | -0.04 |
| Stochastic Oscillator | 73.30 | 67.32 |
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The company operates in segments: Commercial lines insurance, Personal lines insurance, Excess and surplus lines insurance, Life insurance, and Investments. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.